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Introduction: Although vitamin B12 deficiency is a well-known cause of hematological and neuropsychiatric illness,
the presentation of combined severe pancytopenia, demyelination and prominent psychiatric impairment is rare.
Case presentation: We present a case of a previously healthy 55-year-old East African man with severe vitamin B12
deficiency (serum vitamin B12 22pmol/L) secondary to pernicious anemia. He had a severe hypoproliferative
megaloblastic anemia with hemolysis (hemoglobin 61g/L, mean corpuscular volume 99fL, reticulocytes 0.8%,
haptoglobin undetectable), leukopenia (2.7×109/L), thrombocytopenia (96×109/L), ataxia with central demyelination,
and megaloblastic madness. The patient’s anemia, myelopathy and psychiatric condition responded well to parenteral
vitamin B12 replacement therapy, with significant improvement seen within weeks.
Conclusion: Hematological manifestations of vitamin B12 deficiency are typically inversely correlated with the presence
and severity of neuropsychiatric impairment. Although uncommon, a presentation with severe hematological and
neuropsychiatric disease can occur, as illustrated by this case. Its presence may help guide diagnosis as well as provide
clinically important prognostic information.
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Vitamin B12 is essential for normal blood synthesis and
neurological function. Vitamin B12 deficiency may cause
megaloblastic anemia, subacute combined degeneration
of the cord and psychiatric illness (“megaloblastic mad-
ness”). Notably, the degree of bone marrow suppression
is typically inversely related to both the presence and se-
verity of neurological involvement. As such, the coexist-
ence of significant anemia and neurological deficits is
thought to be rare. We describe an unusual case of a pa-
tient with severe vitamin B12 deficiency together with
profound hematological derangements and florid neuro-
psychiatric impairment.
Case presentation
A 55-year-old man of East African descent presented to
our community hospital with a history of repeated falls,* Correspondence: alexander@ualberta.net
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unless otherwise stated.postural dizziness, progressive fatigue, generalized weak-
ness and 30-lb weight loss over the course of three to six
months. He is a vegetarian. His collateral history ob-
tained from family members confirmed a significant be-
havioral change over the past year, during which they
observed irritability and emotional lability, as well as dif-
ficulty with self-care, grooming and personal hygiene.
He was high-functioning before the onset of his present
illness. During a review of systems, he denied any sen-
sory deficits, visual impairment or taste perversion, and
he also denied any history of bleeding, bruising or recent
infection. His past medical history was unremarkable.
He was not taking any medications at the time of pres-
entation. The patient denied smoking, alcohol consump-
tion or illicit drug use. He had no significant family
history of any illness.
The initial examination in the emergency department re-
vealed a poorly groomed, disheveled thin man who appeared
older than his stated age. He was irritable, paranoid, delu-
sional and highly circumstantial and had grandiose thoughts
and impaired insight. He denied any hallucinations. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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change, his pulse was 92 beats/min and his respiratory
rate was 16 breaths/min. He was afebrile. His neurological
examination was limited because he was uncooperative,
but he was observed to have an unstable, wide-based,
ataxic gait as well as difficulty in performing rapid, alter-
nating hand movements. His proprioception, vibration
sense and light-touch sensory modalities appeared grossly
preserved. His reflexes were symmetric and normal. His
cardiovascular, respiratory, abdominal and dermato-
logical examination results were unremarkable. Of note,
he did not have evidence of splenomegaly, oral ulcers, nail
changes or vitiligo. The patient was subsequently admitted
to the hospital for further evaluation.
A complete blood count revealed hemoglobin 61g/L
(mean corpuscular volume 99fL), thrombocytopenia 96×109
and leukopenia 2.7×109. The patient’s reticulocytes were
decreased at 14×109/L (0.8%). A peripheral blood smear
demonstrated hypersegmented neutrophils and schis-
tocytes. His serum vitamin B12 level was decreased at
22pmol/L (reference range 155pmol/L to 700pmol/L),
his serum haptoglobin was undetectable and his serum
lactate dehydrogenase was elevated at 1135U/L. The pa-
tient’s iron studies, folate, thyroid-stimulating hormone,
liver enzymes, fibrinogen, serum protein electrophoresis,
anti–tissue transglutaminase antibodies, hemoglobin A1c,Figure 1 Magnetic resonance imaging scan of the patient’s spine. Thi
area of hyperintensity (indicated by the arrow) along the dorsal column, cocoagulation panel, electrolytes and serum creatinine were
all within normal limits. Viral studies for parvovirus B19,
cytomegalovirus and human immunodeficiency virus were
unremarkable. However, anti–intrinsic factor antibodies
were detected. His blood type was B+. Of note, all blood
work was performed prior to commencing any medical
treatment or blood transfusions.
Computed tomography of the head revealed mild cere-
bral atrophy. Magnetic resonance imaging confirmed the
presence of mild cerebral atrophy with increased signal
intensity throughout the dorsal aspect of the cervical
and thoracic spine, consistent with vitamin B12 myelop-
athy (Figure 1). Chest radiography and computed tom-
ography of the abdomen and pelvis were unremarkable.
The patient did not consent to undergo diagnostic en-
doscopy. The patient was also unwilling to undergo elec-
tromyography with nerve conduction studies.
The diagnosis of severe vitamin B12 deficiency secondary
to pernicious anemia was established on the basis of an un-
equivocally low serum vitamin B12 level and the presence
of anti–intrinsic factor antibodies. The patient’s long-
standing vegetarian diet may also have been a contributor
to his vitamin B12 deficiency. Other causes of pancytopenia
which may be characterized by a hypoproliferative, meg-
aloblastic, macrocytic anemia—such as folate deficiency,
hypothyroidism, viral illness and exposure to potentials sagittal view of the patient’s cervical and thoracic spine shows an
nsistent with demyelination due to vitamin B12 deficiency.
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mal neurological and psychiatric evaluations were also
consistent with central demyelinating disease and megalo-
blastic madness with prominent depressive features, after
potential confounding metabolic and anatomical causes
were excluded.
Because of the profound symptomatic anemia at pres-
entation, the patient was initially given a transfusion of
2U of packed red blood cells upon admission. He was
then initiated on daily subcutaneous injections of vitamin
B12 at 1000μg for one week, followed by weekly injections
for the next four weeks, and he was subsequently pre-
scribed monthly injections to be continued indefinitely.
Within the first week of treatment, the patient’s pancyto-
penia had nearly resolved. His neuropsychiatric symptoms
and cognition had also improved significantly by the time
of hospital discharge. At follow-up three months later, the
patient’s neuropsychiatric impairment had completely
resolved. He denied any psychiatric disturbance, dem-
onstrated a normal gait and had normal reflexes upon
follow-up.
Discussion
Vitamin B12 deficiency is common, with an estimated
prevalence of 15% in patients >60 years of age. Although
most cases are clinically subtle, vitamin B12 deficiency
may sometimes present with florid disease [1,2]. When
present, symptoms and signs can be broadly classified
into hematological and neurological categories. Classically,
vitamin B12 deficiency may give rise to megaloblastic
anemia and sub-acute combined degeneration of the spinal
cord with demyelination of the dorsal column, resulting in
both motor and sensory deficits. Less commonly, hemolysis
and pancytopenia may be detected in the blood work, and
neurological sequelae of optic nerve atrophy, autonomic
nervous system dysfunction, peripheral neuropathy, as
well as psychiatric complications of emotional lability,
mania, paranoia, delusions, amnesia and psychosis, may
also be present [3].
Notably, the degree of megaloblastic anemia in a pa-
tient with vitamin B12 deficiency is inversely correlated
with the presence and severity of neuropsychiatric symp-
toms at the time of presentation [3-6]. Severe anemia is
rarely accompanied by any neurological symptoms or signs
[5]. Likewise, hematocrit and mean corpuscular volume
are commonly normal in patients with neuropsychiatric
abnormalities [3,5]. The underlying reason for this rela-
tionship remains unclear. However, it is postulated that the
mechanism responsible for the neurological dysfunction
associated with vitamin B12 deficiency is altogether differ-
ent from those responsible for the hematological sequelae.
Vitamin B12 acts as a coenzyme for L-methylmalonyl-
coenzyme A mutase and methionine synthetase. Accord-
ingly, enzymatic defects resulting from vitamin B12 deficiencylead to accumulation of methylmalonic acid and homo-
cysteine, which appear to be proportionally related to the
severity of the associated neurological and psychiatric ab-
normalities [4]. In contrast, inadequate vitamin B12 results
in ineffective DNA synthesis and impaired erythropoi-
esis, which account for the majority of the associated
hematological derangements [3]. The underlying mecha-
nisms responsible for the resulting megaloblastic anemia
appear to be altogether different from the processes
that produce the neurological sequelae of vitamin B12
deficiency.
Myelopathy and peripheral neuropathy collectively ac-
count for the vast majority of neurological dysfunction
[6], with mental impairment representing approximately
15% of cases [4,6]. Among patients with neurological dis-
ease, anemia and macrocytosis are the most common
hematological derangements detected, and, when they are
present, anemia and macrocytosis are typically minor and
subtle [4,6]. In contrast, pancytopenia, severe anemia (that
is, <60g/L), hemolysis, leukopenia and thrombocytopenia
are all documented to be rare [2,3,5].
The presence of anemia also carries important prognos-
tic significance. Anemia detected at baseline is inversely
related to the severity of neurological impairment at diag-
nosis. Even after adjusting for differences in age, sex, mean
corpuscular volume, serum vitamin B12 level and disease
duration, a lower hematocrit level remains an independent
predictor of worse neurological disease [5]. It appears that
the presence of anemia at baseline also favors a better
neurological response to treatment and a more favorable
long-term recovery [5].
Conclusion
Pernicious anemia can present with severe hematologic
and neuropsychiatric conditions concurrently, contrary
to stated dogma. Transient, self-limited neurological ex-
acerbations may sometimes occur during the first few
weeks of treatment. However, appropriate therapy can
lead to complete recovery in up to two-thirds of patients
treated [2,3].
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